Back to Agenda
Taiwan Town Hall: Strategies to Promote Medicine Supply Resilience
Session Chair(s)
Chih-Kang Chiang, MD
Director General, Taiwan's Food and Drug Administration (TFDA), Taiwan
This Taiwan Town Hall showcases Taiwan’s evolving approach to medicine supply resilience. It brings together regulators, industry, and health systems from Taiwan, the EU, Japan, and the US to explore coordinated global pathways for critical medicines.
Learning Objective : Explain Taiwan’s transition from medicine shortage management to supply resilience governance; Compare regulator, industry, and health system perspectives from Taiwan, EU, Japan, and US on critical medicines and international cooperation; Identify practical pathways for Taiwan to engage with global partners to strengthen coordinated frameworks for resilient medicine supply.
Speaker(s)
Lawrence Eugene Liberti, RAC
Director, D.K. Kim International Center for Regulatory Science, The Kim Center/ USC DRQS, United States
Academic Perspectives on Strengthening Medicine Supply Resilience
Chih-Kang Chiang, MD
Director General, Taiwan's Food and Drug Administration (TFDA), Taiwan
From Shortage Management to Resilience Governance: Taiwan’s Evolving Policy Approach
Meng-Hsiu Wu, MS
Deputy Director, Division of Medicinal Products, Taiwan's Food and Drug Administration (TFDA), Taiwan
From Regulation to Resilience: Taiwan’s Strategy in Controlled Drug Manufacturing and Future Directions
Masaya Tamae
Deputy General Manager, Corporate Strategy Division, Meiji Seika Pharma., Co., Ltd, Japan
Lessons from Japan: Projects for Enhanced Supply Resilience
Matthew Eberts, PHARMD, MBA, MHA
Senior Director System Pharmacy Business and Outcomes, University of Maryland Medical System, United States
From Shortage to Resilience: Building Medication Supply Preparedness in Health Systems
Have an account?